T-cell therapy could potentially be moved to earlier lines of treatment in relapsed/refractory multiple myeloma based on emerging trial data, improving outcomes through earlier intervention before ...
Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with a weakened ...
Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...
The preclinical studies with astatine-211-labeled murine 81C6 provided a good rationale for initiating a phase I evaluation for intrathecally administered astatine-211-labeled chimeric 81C6 in ...
An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...
Scientists at Guangzhou Imd Therapeutics Co. Ltd. and Pamplona Therapeutics (Shenzhen) Co. Ltd. have described proteolysis targeting chimeric (PROTAC) compounds comprising cereblon (CRBN) ligands ...
This important study describes how a single effector of the Type Six Secretion System (T6SS) has two distinct functions, which may contribute to bacterial survival and the development of novel ...
a fully-human anti-VEGF monoclonal antibody; HALPRYZA, a recombinant chimeric murine/human anti-CD20 monoclonal antibody; SULINNO, a fully-human antiTNF-a monoclonal antibody; Pemazyre ...
islet cell antibodies, etc. The most common treatment for T1D is the injection of artificial insulin preparations, but this does not provide a cure. Zhang et al. (19) used mAb287 chimeric antigen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback